Nuwellis, Inc.
Nuwellis, Inc. (NUWE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NUWE · as of Jun 9, 2026
Key Statistics
Explore Nuwellis, Inc. Data
nuwe stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
nuwe competitorsNUWE
ACON
BACK
BCTXW
IVF
NUVOStock Performance
Full HistoryAbout Nuwellis, Inc.
Nuwellis, Inc. is a medical device firm specializing in the creation, production, and commercialization of devices for ultrafiltration therapy. Its primary offerings, the Aquadex FlexFlow and Aquadex …
what is nuwellis, inc. · nuwe stock overview · nuwellis, inc. company profile · who is nuwellis, inc. ceo · nuwe NASDAQ · nuwellis, inc. headquarters · nuwellis, inc. business segments
About Stock Overview & Key Data
Nuwellis, Inc. (NUWE) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 16, 2012. As of the latest trading session, NUWE stock price is $0.14, with a market capitalization of $130,886. The stock has returned -98.50% over the past 12 months and -91.67% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Nuwellis, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Nuwellis, Inc. reported revenue of $8.3M and net income of -$17.5M. For detailed data — including Nuwellis, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nuwellis, Inc. (NUWE) stock price is $0.14. The stock is traded on NASDAQ under the ticker symbol NUWE. The 52-week range is $0.13 – $25.95.